What is Coya Therapeutics, Inc. Common Stock's Market Cap?

Coya Therapeutics, Inc. Common Stock's Market Cap is $106.0M, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's Enterprise Value?

Coya Therapeutics, Inc. Common Stock's Enterprise Value is $62.8M, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's Price / Sales?

Coya Therapeutics, Inc. Common Stock's Price / Sales is 13.2×, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's EV / Revenue?

Coya Therapeutics, Inc. Common Stock's EV / Revenue is 7.8×, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's EV / EBITDA?

Coya Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's Revenue (TTM)?

Coya Therapeutics, Inc. Common Stock's Revenue (TTM) is $8.0M, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's Net Income (TTM)?

Coya Therapeutics, Inc. Common Stock's Net Income (TTM) is -$21.7M, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's EBITDA?

Coya Therapeutics, Inc. Common Stock's EBITDA is -$23.1M, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Coya Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.

What is Coya Therapeutics, Inc. Common Stock's EBITDA Margin?

Coya Therapeutics, Inc. Common Stock's EBITDA Margin is -288.5%, based on as-reported figures from SEC (XBRL) filings.

Coya Therapeutics, Inc. Common Stock (COYA) Financial Statements

Coya Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Z4HBCC8

XNAS · usd

4.52▼ 0.09 (-1.95%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close4.61

Day's Range4.46 – 4.62

52-Week Range3.71 – 7.75

Volume93.4K

Avg Volume108.2K

Share Statistics

Shares Outstanding

Employees8

ExchangeXNAS

Listed2022-12-29

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Coya Therapeutics, Inc. Common Stock (COYA)

What is Coya Therapeutics, Inc. Common Stock's Market Cap?: Coya Therapeutics, Inc. Common Stock's Market Cap is $106.0M, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's Enterprise Value?: Coya Therapeutics, Inc. Common Stock's Enterprise Value is $62.8M, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's Price / Sales?: Coya Therapeutics, Inc. Common Stock's Price / Sales is 13.2×, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's EV / Revenue?: Coya Therapeutics, Inc. Common Stock's EV / Revenue is 7.8×, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's EV / EBITDA?: Coya Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's Revenue (TTM)?: Coya Therapeutics, Inc. Common Stock's Revenue (TTM) is $8.0M, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's Net Income (TTM)?: Coya Therapeutics, Inc. Common Stock's Net Income (TTM) is -$21.7M, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's EBITDA?: Coya Therapeutics, Inc. Common Stock's EBITDA is -$23.1M, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Coya Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.
What is Coya Therapeutics, Inc. Common Stock's EBITDA Margin?: Coya Therapeutics, Inc. Common Stock's EBITDA Margin is -288.5%, based on as-reported figures from SEC (XBRL) filings.